IOVA and REPL Related Headlines

Go Back

Jul 22, 2025 08:50AM Barclays Reiterates Overweight Rating on Replimune Group (REPL), PT $17, 'We see this as a clear positive for Iovance's Amtagvi'

IOVA and REPL Related Press Releases

Go Back

IOVA and REPL Related SEC Filings

Go Back